JK-05', China's first Ebola drug has been approved for the treatment of
the disease. The drug was developed by the Academy of Military Medical
Sciences.
According to CNTV, the research team spent the last five years studying
Ebola’s prevention and treatment, and the drug has shown anti-Ebola
activity during cell experiments and testing.
It also recently completed pre-clinical testing as well as a
clinical-safety evaluations. However, so far the drug has only been
cleared for use in emergency situations.
"JK-05 is a micro-molecular chemical, and its pharmacological mechanism
is to selectively contain the RNA polymerase of the Ebola virus so as to
inhibit virus replication." said Prof. Wang Hongquan, China Academy of
Military Medical Sciences.
#Ebola #China #CNTV #JK05

No comments:
Post a Comment